Company Overview and News

1
LNC / Lincoln National Corp. LNC FORM 8-K JULY 13, 2018 (Current Report)

2018-07-17 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
LNC

2
5 Solid Reasons to Hold ProAssurance in Your Portfolio

2018-07-12 zacks
ProAssurance Corporation (PRA - Free Report) has been witnessing solid improvement over the past few quarters, majorly driven by acquisitions, accretive to premiums. Shares of this Zacks Rank #3 (Hold) company have gained 5.5% quarter to date, outperforming 2.2% growth recorded by the industry. The company flaunts a value score of B. If you haven’t taken advantage of the share price appreciation yet, it is time for you to retain the stock in your portfolio as it looks promising and is poised to carry the momentum ahead, driven by the following factors.
LNC LNC.WS PGR FAF PRA

5
5 Top-Ranked Insurance Stocks to Enhance Portfolio in 2H

2018-07-06 zacks
A favorable operating environment has set the stage for insurers to perform well through the second half of 2018. Though macro factors like interest rate hike, trade tariffs, rise in oil prices and inflation rate should continue to render volatility in markets and sectors, the insurance industry is expected to push limits, banking on inherent strength cushioned by a beneficial operating environment.
LNC AIZ HIG RE PGR

2
Does a Fall in Lincoln National Make It a Good Bargain?

2018-07-05 zacks
Lincoln National Corp.’s (LNC - Free Report) favorable operating performance for the past many quarters is backed by its powerful retail franchise, which brings together a comprehensive and expanding product portfolio with distribution breadth. Though the stock has lost 9% in a year’s time compared with the industry’s decline of 6%, we expect progress on its fundamentals to help it bounce back.
LNC LNC.WS GWGH

0
LNC / Lincoln National Corp. 11-K

2018-06-29 sec.gov
2017 - Employees' 401k plan UNITED STATES SECURITIES AND EXCHANGE COMMISSION
LNC

1
LNC / Lincoln National Corp. 11-K

2018-06-29 sec.gov
2017 Agents 11K  
LNC

18
5 Undervalued Large-Cap Stocks For Value Investors - June 2018

2018-06-28 seekingalpha
NWL, PFG, GILD, VZ, and LNC are all rated as suitable for the Defensive Investor and/or the Enterprising Investor following the ModernGraham approach.
NWL LNC PFG GILD LNC.WS VZ VZA

109
Top Analyst Reports for United Technologies, PayPal & ConocoPhillips

2018-06-12 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including United Technologies (UTX), PayPal (PYPL) and ConocoPhillips (COP). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
COF.PRG COF.PRH BCS OIL COF.WS COF.PRP COP COF-D 83SF COF-C COF-F 83SK ICE COF.PRC COF.PRD 47MC COF.PRF COF-P UNP LNC.WS COF UTX ANTM PVH LNC OXY

60
Brighthouse Financial: Attractive Short And Market Hedge

2018-06-12 seekingalpha
In my opinion, BHF’s steep discount relative to book value is a trap, not an opportunity.
BHF LNC GE MET LNC.WS CI GNW

0
Insurer Lincoln National could see upside -Barron's

2018-06-03 reuters
NEW YORK (Reuters) - U.S. insurer Lincoln National Corp could deliver shareholder returns of 20 percent or more in the coming year, as the market for the company’s main product, variable annuities, recovers, Barron’s reported.
LNC PUK.PRA PUK PUK.PR LNC.WS PUKPF

4
Weighing The Week Ahead: Is It Time To Worry About A Trade War?

2018-06-03 seekingalpha
Last week's loaded economic calendar had little effect on stock prices, although the news remains positive.
LNC LNC.WS KMB MMM

936
0
LNC / Lincoln National Corp. LNC FORM 8-K (Current Report)

2018-05-30 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
LNC

0
LNC / Lincoln National Corp. FORM S-3 FOR 2009 ICP

2018-05-28 sec.gov
As filed with the Securities and Exchange Commission on May 25, 2018 File No. 333-
LNC

80
Top Analyst Upgrades and Downgrades: AMC, Alkermes, Echostar, Kohls, L Brands, US Bancorp, Sarepta Therapeutics and More

2018-05-11 247wallst
The futures traded just a touch higher Friday morning as the market continued to digest some big gains from the past two weeks. Stocks took off once again yesterday when the inflation numbers were reported and came in reasonably tame and below expectations, with no big jumps to the upside on costs. The consumer price index rose 0.2% in April, which was below estimates.
WFCNP WFC.PRL WFC.PRJ LB WFC.PRT SATS WFC.PRR WFC.PRQ WFC.PRP AMCX WFC.PRO WFC.PRN KSS WFC.PRY WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS ALKS LNC.WS SRPT LNC EEFT TRI

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to LNC / Lincoln National Corp. on message board site Silicon Investor.

Valence Technology- How low can it go? (VLNC) VALENCE TECHNOLOGY (VLNC)
LNCR: Lincare Holdings Inc. Lincare Holdings (LNCR)
GLNC RTO of Millennium Multi-Media Lincoln National (LNC:NYSE)
Lancit Media LNCT- The right place at the right time Better Batteries: VLNC and ULBI